Understanding MINOCA and the Need for Better Diagnostics
Myocardial infarction with non-obstructive coronary arteries, commonly known as MINOCA, represents a significant clinical challenge in cardiology. Patients present with symptoms and biomarkers consistent with acute myocardial infarction yet show no significant blockages on coronary angiography. This condition accounts for approximately 5 to 15 percent of all myocardial infarctions, affecting a diverse patient population worldwide.
Traditional approaches often leave many cases without a clear underlying cause, leading to uncertainty in management. A new prospective multicenter study led by researchers including Kensuke Nishimiya, Behruz Yosofi, Aukelien C. Dimitriu-Leen, Rick H.J.A. Volleberg, Jeroen Jaspers Focks, Giel van Helden, Tijn P.J. Jansen, Cyril Camaro, Tim C. ten Cate, Marleen van Wely, Lokien X. van Nunen, Jos Thannhauser, Suzette Elias-Smale, Robert Jan van Geuns, Niels van Royen, Robin Nijveldt, and Peter Damman addresses this gap through a structured diagnostic protocol. The full publication is available at https://www.sciencedirect.com/science/article/pii/S0002914926004285.
The Study Design and Patient Cohort
The research involved a prospective multicenter cohort of patients who underwent invasive coronary angiography between December 2020 and June 2024. Eligible participants met the universal definition of myocardial infarction while demonstrating non-obstructive coronary arteries, defined as less than 50 percent stenosis in potential infarct-related vessels. The protocol incorporated a stepwise multimodal approach starting with optical coherence tomography during catheterization, followed by left ventriculography or echocardiography, and cardiac magnetic resonance imaging where appropriate.
This design allowed investigators to assess both the feasibility of implementing such a protocol in routine clinical settings and its incremental diagnostic yield. By combining intracoronary imaging with noninvasive modalities, the team aimed to identify specific etiologies such as plaque disruption, spontaneous coronary artery dissection, myocarditis, takotsubo cardiomyopathy, or microvascular dysfunction.
Key Findings on Diagnostic Yield
Analysis of 183 patients revealed substantial improvements in diagnostic clarity when modalities were used in combination. Optical coherence tomography alone identified an underlying cause in roughly 20 percent of cases. Adding left ventriculography or echocardiography raised the yield to approximately 37 percent. Incorporating cardiac magnetic resonance imaging further increased the overall diagnostic rate to around 62 percent in the combined protocol.
These incremental gains highlight how no single test captures the full spectrum of MINOCA etiologies. The structured sequence proved practical, with most patients completing the protocol without significant delays or complications. Results underscore the value of early, comprehensive evaluation rather than relying on angiography alone.
Clinical Implications for Patient Management
Accurate identification of the underlying mechanism enables tailored therapies. For instance, patients with plaque erosion or rupture may benefit from specific antiplatelet strategies, while those with myocarditis require different immunosuppressive or supportive care. Misclassification can lead to inappropriate treatments, such as prolonged dual antiplatelet therapy in non-ischemic conditions.
The study supports broader adoption of multimodal protocols in centers equipped with optical coherence tomography and cardiac magnetic resonance capabilities. It also emphasizes the importance of timely imaging, as delays can reduce the sensitivity of certain findings, particularly on cardiac magnetic resonance.
Comparison with Prior Research and Guidelines
Previous investigations, including those from the American Heart Association scientific statement on MINOCA, have advocated for systematic evaluation beyond angiography. The current work builds on those recommendations by demonstrating real-world feasibility and quantifiable yield improvements in a contemporary European cohort.
Related position papers from the European Society of Cardiology have similarly stressed the heterogeneous nature of MINOCA and the role of advanced imaging. This new evidence provides concrete data on how combining optical coherence tomography with ventricular assessment and cardiac magnetic resonance can outperform isolated approaches, aligning with calls for precision in cardiovascular diagnostics.
Further reading on established frameworks is available through the AHA statement at https://www.ahajournals.org/doi/10.1161/CIR.0000000000000670 and ESC resources on acute coronary syndromes.
Challenges in Implementation and Potential Solutions
Despite promising results, barriers remain. Access to optical coherence tomography requires specialized catheters and operator expertise, while cardiac magnetic resonance availability varies by region and institution. Logistical coordination between catheterization labs and imaging departments can also pose hurdles.
The study suggests solutions such as standardized referral pathways and training programs for interventional cardiologists in intracoronary imaging. Multidisciplinary teams involving cardiologists, radiologists, and imaging specialists can streamline the process. Cost-effectiveness analyses will be important for wider adoption, particularly in resource-limited settings.
Future Directions and Research Opportunities
Building on these findings, larger randomized trials could evaluate whether protocol-driven diagnosis translates into improved clinical outcomes, such as reduced recurrent events or better symptom control. Integration of artificial intelligence for image analysis may further enhance efficiency and accuracy.
Additional studies exploring vasoreactivity testing or intravascular ultrasound as adjuncts could refine the protocol. Long-term follow-up of the current cohort will provide insights into prognosis based on specific diagnoses. The work opens avenues for personalized medicine in a condition previously managed empirically.
Perspectives from the Research Community
Cardiology experts note that MINOCA has long been a diagnosis of exclusion, often leaving patients and clinicians frustrated. This protocol shifts the paradigm toward active investigation. The multicenter nature strengthens generalizability across different healthcare systems.
Stakeholders, including hospital administrators and policymakers, may consider incorporating such pathways into acute coronary syndrome protocols. For academic researchers, the dataset offers opportunities for secondary analyses on subgroups, such as sex-specific differences or regional variations in etiology prevalence.
Photo by Pawel Czerwinski on Unsplash
Actionable Insights for Clinicians and Institutions
Hospitals interested in adopting similar approaches can begin by auditing current MINOCA management practices and identifying gaps in imaging access. Pilot programs combining optical coherence tomography with cardiac magnetic resonance in select cases can demonstrate local feasibility.
Education initiatives for trainees and staff on MINOCA heterogeneity are essential. Collaboration with professional societies can facilitate guideline updates that reflect emerging evidence from studies like this one.
Broader Impact on Cardiovascular Care
Improved diagnostic precision in MINOCA has ripple effects beyond individual patients. It can reduce unnecessary procedures, optimize medication use, and enhance risk stratification. In an era of value-based care, such efficiencies matter.
Globally, the findings contribute to ongoing efforts to standardize MINOCA evaluation, potentially influencing updates to international guidelines. As awareness grows, more patients may receive timely, mechanism-specific interventions rather than generic post-infarction care.
